Table 1 Characteristics of patients treated in the HIV program stratified by survey participation
Lost to follow-up, transferred, dead | Did not respond to survey | Responded to survey | Total | P value | |
|---|---|---|---|---|---|
Number | 93 | 77 | 164 | 334 | |
Sex | 0.664 | ||||
Male | 61 (65.6%) | 46 (59.7%) | 107 (65.2%) | 214 (64.1%) | |
Female | 32 (34.4%) | 31 (40.3%) | 57 (34.8%) | 120 (35.9%) | |
Transmission | 0.005 | ||||
PDA | 35 (37.6%) | 18 (23.4%) | 42 (25.t6%) | 95 (28.4%) | |
Unknown | 1 (1.1%) | 5 (6.5%) | 2 (1.2%) | 8 (2.4%) | |
MSM | 15 (16.1%) | 14 (18.2%) | 56 (34.1%) | 85 (25.4%) | |
Heterosexual | 42 (45.2%) | 40 (51.9%) | 62 (37.8%) | 144 (43.2%) | |
Blood transfusion | 0 (0.0%) | 0 (0.0%) | 1 (0.6%) | 1 (0.3%) | |
Vertical | 0 (0.0%) | 0 (0.0%) | 1 (0.6%) | 1 (0.3%) | |
Country of origin | 0.024 | ||||
Spain | 56 (60.2%) | 36 (46.8%) | 107 (65.2%) | 199 (59.6%) | |
Other | 37 (39.8%) | 41 (53.2%) | 57 (34.8%) | 135 (40.4%) | |
Age at first visit, years | 44.2 (37.2;49.3) | 41.6 (31.9;48.8) | 42.1 (34.1;47.4) | 42.3 (34.6;48.5) | 0.645 |
Viral load at first visit | |||||
Undetectable (< 50 copies/ml) | 34 (36.6%) | 39 (50.6%) | 62 (37.8%) | 135 (40.4%) | 0.143 |
CD4+ cell count at first visit (cells/mm3) | 413.0 (179.0;639.0) | 491.0 (237.0;747.0) | 474.0 (215.5;698.0) | 457.0 (219.0;685.0) | 0.227 |
Years of follow-up | 1.0 (0.2;1.8) | 4.3 (2.9;5.1) | 3.6 (2.0;4.8) | 2.9 (1.0;4.6) | < 0.001 |